CLINICAL CHARACTERISTICS: Cornelia de Lange syndrome (CdLS) encompasses a spectrum of findings from mild to severe. Severe (classic) CdLS is characterized by distinctive facial features, growth failure (often prenatal onset; height and weight <5th centile throughout life), hypertrichosis, and limb abnormalities (e.g., complete absence of elbow and forearms, oligodactyly [missing digits], micromelia [small hands],...
Audiologists seeing patients with CdLS should be aware of associated hearing loss (conductive, sensorineural, or mixed) and ensure regular audiological monitoring is part of the multidisciplinary care plan; no new clinical guidance beyond standard syndromic hearing loss management is introduced here.
CdLS is one of many genetic syndromes where hearing loss is a frequently overlooked component, and awareness of its audiological profile supports earlier identification and intervention in this population.
- 01CdLS is a genetic syndrome with a broad spectrum of features, including hearing loss as a recognized component.
- 02Hearing loss in CdLS can be conductive (sound not passing through the ear properly), sensorineural (inner ear or nerve damage), or mixed.
- 03GeneReviews entries are authoritative, regularly updated references aimed at clinicians managing genetic conditions.
- 04The 2026 update reflects the most current understanding of CdLS genetics and clinical management.
- 05Audiology relevance is tangential — the article is primarily a genetics resource, not an audiology-specific publication.
Cornelia de Lange Syndrome is associated with hearing loss as part of its clinical spectrum.
guidelinesupported- PMID
- 20301283
- Journal
- GeneReviews (NCBI Bookshelf)
- Publication type
- review
- Evidence level
- 5
- Population
- Individuals with Cornelia de Lange Syndrome across the clinical spectrum, including pediatric and adult patients
- Intervention
- Clinical characterization and genetic review of Cornelia de Lange Syndrome
Primary outcomes
Clinical diagnostic criteria and genetic variants associated with CdLS; Management recommendations across organ systems including hearing